{"title":"Carbon Nanotubes for Targeted Cancer Therapy","authors":"R. Zeineldin","doi":"10.1002/9783527610419.NTLS0241","DOIUrl":null,"url":null,"abstract":"The sections in this article are \n \n \nIntroduction \nCancer \nConventional Cancer Chemotherapy versus Nanocarrier-Mediated Drug Delivery \nChallenges with Chemical Compounds as Therapeutic Agents \nAdvantages of Nanocarriers as Drug-Delivery Vehicles \n \n \nCarbon Nanotubes as Drug-Delivery Vehicles \nCellular Uptake of CNTs \nFunctionalization of CNTs with Polyethylene Glycol \nTargeting of Cancers \nPassive Targeting \nActive Targeting \nTrafficking of Targeted Drug-Delivery Vehicles \n \n \nTargeted Cancer Therapy Employing CNTs and a Critique of Current Studies \nerbB Family Members \nFolate Receptor α \nBiotin Receptor \nIntegrins \nMarkers for Lymphomas or Leukemias \nDisialoganglioside (GD2) \n \n \nSummary and Future Perspective \nAcknowledgments \n \n \nKeywords: \n \nCarbon nanotubes; \nsingle-walled carbon nanotubes; \nmulti-walled carbon nanotubes; \ncancer; \ntargeting; \nPEGylation; \ndrug delivery","PeriodicalId":312946,"journal":{"name":"Nanotechnologies for the Life Sciences","volume":"20 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2012-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanotechnologies for the Life Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/9783527610419.NTLS0241","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
Abstract
The sections in this article are
Introduction
Cancer
Conventional Cancer Chemotherapy versus Nanocarrier-Mediated Drug Delivery
Challenges with Chemical Compounds as Therapeutic Agents
Advantages of Nanocarriers as Drug-Delivery Vehicles
Carbon Nanotubes as Drug-Delivery Vehicles
Cellular Uptake of CNTs
Functionalization of CNTs with Polyethylene Glycol
Targeting of Cancers
Passive Targeting
Active Targeting
Trafficking of Targeted Drug-Delivery Vehicles
Targeted Cancer Therapy Employing CNTs and a Critique of Current Studies
erbB Family Members
Folate Receptor α
Biotin Receptor
Integrins
Markers for Lymphomas or Leukemias
Disialoganglioside (GD2)
Summary and Future Perspective
Acknowledgments
Keywords:
Carbon nanotubes;
single-walled carbon nanotubes;
multi-walled carbon nanotubes;
cancer;
targeting;
PEGylation;
drug delivery